DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $132,593,820 | +157.8% | 534,437 | +149.4% | 0.82% | +171.6% |
| Q2 2023 | $51,438,960 | -36.7% | 214,329 | -33.5% | 0.30% | -40.9% |
| Q1 2023 | $81,220,646 | +3.8% | 322,253 | +9.3% | 0.51% | 0.0% |
| Q4 2022 | $78,278,994 | +19.2% | 294,925 | +16.0% | 0.51% | +12.5% |
| Q3 2022 | $65,687,000 | +106.4% | 254,316 | +102.6% | 0.46% | +118.2% |
| Q2 2022 | $31,828,000 | +11.0% | 125,546 | +28.5% | 0.21% | +34.0% |
| Q1 2022 | $28,667,000 | -66.1% | 97,729 | -62.0% | 0.16% | -65.2% |
| Q4 2021 | $84,674,000 | -4.4% | 257,361 | -11.5% | 0.45% | -5.3% |
| Q3 2021 | $88,579,000 | +317.8% | 290,956 | +268.3% | 0.47% | +314.9% |
| Q2 2021 | $21,202,000 | +28.0% | 79,006 | +7.3% | 0.11% | +22.6% |
| Q1 2021 | $16,569,000 | +0.3% | 73,615 | -1.0% | 0.09% | -5.1% |
| Q4 2020 | $16,519,000 | -19.2% | 74,363 | -21.7% | 0.10% | -23.4% |
| Q3 2020 | $20,445,000 | -5.7% | 94,946 | -22.6% | 0.13% | -7.2% |
| Q2 2020 | $21,691,000 | +25.9% | 122,666 | -1.4% | 0.14% | +13.1% |
| Q1 2020 | $17,223,000 | -55.4% | 124,432 | -50.5% | 0.12% | -30.3% |
| Q4 2019 | $38,612,000 | -1.6% | 251,576 | -7.4% | 0.18% | -3.3% |
| Q3 2019 | $39,257,000 | -48.1% | 271,806 | -48.6% | 0.18% | -46.4% |
| Q2 2019 | $75,583,000 | -11.8% | 528,846 | -18.5% | 0.34% | -11.3% |
| Q1 2019 | $85,651,000 | +7.7% | 648,773 | -15.8% | 0.38% | +3.0% |
| Q4 2018 | $79,494,000 | -9.5% | 770,891 | -4.6% | 0.37% | +12.1% |
| Q3 2018 | $87,803,000 | +8.9% | 808,053 | -1.1% | 0.33% | +3.1% |
| Q2 2018 | $80,655,000 | +259.6% | 817,338 | +256.8% | 0.32% | +263.6% |
| Q1 2018 | $22,430,000 | -38.2% | 229,093 | -41.4% | 0.09% | -35.3% |
| Q4 2017 | $36,293,000 | -12.4% | 391,005 | -19.0% | 0.14% | -17.1% |
| Q3 2017 | $41,414,000 | +9.7% | 482,796 | +7.9% | 0.16% | +7.9% |
| Q2 2017 | $37,768,000 | -17.7% | 447,545 | -16.5% | 0.15% | -20.4% |
| Q1 2017 | $45,869,000 | +117.9% | 536,290 | +98.3% | 0.19% | +99.0% |
| Q4 2016 | $21,051,000 | +856.0% | 270,436 | +862.6% | 0.10% | +860.0% |
| Q3 2016 | $2,202,000 | -9.6% | 28,093 | +16.4% | 0.01% | -16.7% |
| Q2 2016 | $2,437,000 | -56.3% | 24,128 | -58.9% | 0.01% | -57.1% |
| Q1 2016 | $5,574,000 | +1.1% | 58,759 | -1.0% | 0.03% | +3.7% |
| Q4 2015 | $5,511,000 | -33.7% | 59,336 | -39.2% | 0.03% | -38.6% |
| Q3 2015 | $8,316,000 | -64.7% | 97,599 | -64.6% | 0.04% | -62.7% |
| Q2 2015 | $23,576,000 | -0.7% | 275,455 | -1.5% | 0.12% | -2.5% |
| Q1 2015 | $23,746,000 | -10.3% | 279,692 | -9.4% | 0.12% | -10.4% |
| Q4 2014 | $26,471,000 | +20.2% | 308,847 | +6.6% | 0.14% | +26.2% |
| Q3 2014 | $22,018,000 | -7.1% | 289,784 | -3.8% | 0.11% | -7.0% |
| Q2 2014 | $23,712,000 | -14.0% | 301,186 | -18.1% | 0.12% | -11.5% |
| Q1 2014 | $27,566,000 | -16.9% | 367,551 | -14.4% | 0.13% | -15.6% |
| Q4 2013 | $33,161,000 | +81.5% | 429,545 | +62.9% | 0.15% | +71.1% |
| Q3 2013 | $18,275,000 | -27.2% | 263,625 | -33.6% | 0.09% | -29.7% |
| Q2 2013 | $25,116,000 | – | 396,783 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |